First Turn Management »

EXACT Sciences Corporation shares owned by First Turn Management

Quarter-by-quarter ownership of EXACT Sciences Corporation (EXAS) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in EXACT Sciences Corporation

Tip: Access up to 7 years of quarterly data

All positions including EXACT Sciences Corporation held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in EXACT Sciences Corporation by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $13M 301k 43.29
2024-12-31 $17M 310k 56.19

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding EXACT Sciences Corporation

FMR
Vanguard Group
Capital World Investors
BlackRock
Wellington Management Company
State Street Corporation
Ameriprise Financial
Citadel Advisors
Massachusetts Financial Services
Geode Capital Management
Mackenzie Financial
Holocene Advisors
Canada Pension Plan Investment Board
William Blair Investment Management
Champlain Investment Partners

View all funds holding EXACT Sciences Corporation